AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Jul 31 2022
News
L.A. County dodges face-mask mandate as community transmission rates stabilize, and U.S. government orders 66 million doses of Moderna’s pending booster
Los Angeles County has dropped a plan for a universal indoor face-mask mandate as COVID cases and hospitalizations have stabilized, with community transmission expected to fall to “medium” from “high” in the coming weeks.
Health Director Barbara Ferrer had said two weeks ago that the U.S.’s most populous county could again require face coverings if trends in hospital admissions
MarketWatchMar 09 2021
News
New study warns Pfizer and Moderna COVID-19 vaccines could be far less effective against South Africa variant
Despite the increasing global circulation of COVID-19 vaccines, the variants of the virus that emerged in late 2020 may disrupt the world’s mission to achieve herd immunity, according to a new study approved for publishing in the journal Nature.
Researchers specifically look at the South African COVID-19 mutation, scientifically dubbed B.1.351, analyzing whether or not these pathogens
The HillNov 23 2020
News
Pfizer and Moderna use mRNA in their COVID-19 vaccines. This never-before-used technology could transform how science fights diseases.
The success of two COVID-19 candidate vaccines marks a turning point in the long history of vaccines and could lead to major advances against a variety of diseases.
Vaccines developed by Pfizer/BioNTech and Moderna are more than 95% effective against COVID-19, trials show. Both depend on a technology never before used in a commercial vaccine that could upend the way future ones are made
USA TODAYDec 18 2020
Headline Roundup
FDA Authorizes Moderna's COVID-19 Vaccine
The Food and Drug Administration (FDA) approved biotech company Moderna's COVID-19 coronavirus vaccine for emergency use Friday. Nearly 6 million doses of the vaccine could be distributed as early as this weekend. Moderna developed the drug in partnership with the National Institutes of Health; late-stage clinical trials found it to be nearly 95% effective at preventing the illness.
The
Townhall NBC News (Online) ReutersNov 30 2020
Headline Roundup
Moderna to Ask FDA to Approve Its Vaccine
Biotech company Moderna said it would ask the Food and Drug Administration (FDA) and the European Medicines Agency to allow emergency use of its COVID-19 coronavirus vaccine Monday. New study results suggest the shots offer strong protection, with 94.1% effectiveness.
The FDA approval would likely clear the way for the vaccine to be authorized for use in the United States within weeks
Wall Street Journal (News) Washington Examiner PoliticoOct 29 2020
Headline Roundup
Moderna Advances COVID-19 Vaccine Development
Moderna executives said in a press release Thursday that the company is on track to report early data from a late-stage trial of its experimental COVID-19 coronavirus vaccine, after initial results of its 30,000 person trial come in. The company said it expects to apply for authorization from the Food and Drug Administration (FDA) in early December if all requirements are met. The FDA requires
Newsmax (News) The Hill BloombergJul 27 2020
Headline Roundup
Moderna, NIH Advance Coronavirus Vaccine Trials
In partnership with the National Institutes of Health, biotechnology company Moderna plans to enroll roughly 30,000 subjects in Phase 3 of its COVID-19 coronavirus vaccine trial. The Biomedical Advanced Research and Development Authority have awarded Moderna another $472 million to fill the gap in needed funds. This brings the company's U.S.-based financial backing to roughly $955 million.
The Boston Globe CNET Newsmax (News)Oct 21 2021
News
CDC gathers to discuss which patient groups should get Moderna and J&J COVID-19 vaccine boosters, and Pfizer reports positive results from booster trial
There was a flurry of positive news on vaccine boosters Thursday, as the Centers for Disease Control and Prevention gathered to discuss which patient groups should be eligible for boosters developed by Moderna and Johnson & Johnson.
The meeting follows a decision Wednesday by the Food and Drug Administration to allow those boosters, marking a big step toward expanding the booster
MarketWatchOct 22 2021
Headline Roundup
CDC Approves Booster Shots from Moderna, J&J
The Centers for Disease Control and Prevention (CDC) on Thursday approved booster shots of the COVID-19 vaccines from Moderna and Johnson & Johnson.
A CDC advisory panel recommended the extra doses Thursday, and CDC director Rochelle Walensky gave her final approval later in the day. The CDC also said people can get a booster of a different vaccine than the one they received
Associated Press CBS News (Online) The Epoch TimesNov 16 2020
News
Moderna's candidate COVID-19 vaccine looks to protect 94.5% of those who get it, trial shows. 'This makes me giddy,' one doctor says.
A second COVID-19 candidate vaccine looks to be even more effective than the first, with both protecting more than 90% of those who get the shots.
Moderna, a Cambridge, Massachusetts-based biotechnology company, announced early Monday that its candidate vaccine, mRNA-1273, developed in collaboration with the U.S. government, appears to be 94.5% effective against the disease.
USA TODAY